drugset / Trial / NCT00333086

A Study of Letrozole in the Treatment of Endometrial Cancer

NCT00333086 ↗

NaSingle-groupOpen-labelTreatment

Summary

Currently available treatments for endometrial cancer are associated with limited efficacy and significant toxicity. This study will assess the safety and efficacy of letrozole, an aromatase inhibitor, on endometrial cancer.

Timeline

Start
2000-01
Primary completion
2006-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified — —

Indications